IR Contact

Investor Relations And Corporate Communications

Temre Johnson

Investor Relations and Corporate Communications Director
Mirati Therapeutics
858-332-3562
ir@mirati.com

Name *

Email *

Subject *

Comments *



Enter the code shown above.

Investor Contact

Temre Johnson

Investor Relations and Corporate Communications
Mirati Therapeutics
858-332-3562
ir@mirati.com

Quick Links

Investor FAQ's
Governance
SEC Filings

Investor Alerts

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At Mirati Therapeutics, Inc., we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to Mirati Therapeutics, Inc. to send you the requested Investor Email Alert updates.

* Required

Email Address *

Investor Alert Options *

News
Annual Reports
SEC Filings
End of Day Stock Quote



Enter the code shown above.